<ici-import>
	<journal issn="1409-7621"/>
	<issue number="1" volume="45" year="2022" publicationDate="2022-03-15T11:00:00" coverDate="March 2022" coverUrl="https://macvetrev.mk/Files/Issues/Vol%2045/1/Cover_Vol.45No1.jpg" numberOfArticles="10">
		<article externalId="2022-0015">
			<type>ORIGINAL_ARTICLE</type>
			<languageVersion language="en">
				<title>Hyperthyroidism in the domestic cat (felis catus): informed treatment choice based on survival analysis</title>
				<abstract>Hyperthyroidism is the most frequently diagnosed endocrine disorder in cats. Therapy may include pharmacological, surgical (thyroidectomy), radioactive (iodine), and dietary treatment. The choice of treatment is believed to be strongly influenced by the veterinarian’s experience, level of education, and knowledge of the current scientific literature. The history of survival rates can affect the decision for treatment by both the veterinarian and the owner. This study aimed to explore the longevity in cats diagnosed with hyperthyroidism and to identify significant variables which affect survival rates by using retrospective data from the practice. A multivariate Cox regression was applied with the following results: surgical thyroidectomy and methimazole medication produced similar longevity (median 23.5 months, P>0.05); Domestic Short Hair cats survived longer than pure breeds (median 27.2 vs 9.4 months, P &lt; 0.05); as do cats without chronic renal disease (median 28.1 vs 6.2 months, P &lt; 0.001); and those with low activities of alanine aminotransferase (median 27.1 vs 17.0 months, P &lt; 0.01). Hyperthyroidism is comorbid with renal diseases, but no cumulative effect was found on survivability. There was no difference in survival rates between surgical and pharmaceutical treatment, therefore the discussion of treatment options with owners can focus on other factors (e.g., cost, owners’ compliance, cats’ tolerance to medication, presence of comorbidities). We propose that surgery may be the preferred treatment when the survival rates are expected to be higher than one year. This would avoid high costs and potential side effects of medication.</abstract>
				<pdfFileUrl>https://macvetrev.mk/Files/Article/2022/10.2478/macvetrev-2022-0015/macvetrev-2022-0015.pdf</pdfFileUrl>
				<publicationDate>2022-03-15T09:00:00</publicationDate>
				<pageFrom>71</pageFrom>
				<pageTo>78</pageTo>
				<doi>10.2478/macvetrev-2022-0015</doi>
				<keywords>
					<keyword>cats</keyword>
					<keyword>hyperthyroidism</keyword>
					<keyword>methimazole treatment</keyword>
					<keyword>survivability</keyword>
					<keyword>thyroidectomy</keyword>
				</keywords>
			</languageVersion>
			<authors>
				<author>
					<name>Fernando</name>
					<name2></name2>
					<surname>Mata</surname>
					<email>fernandomata@ipvc.pt</email>
					<polishAffiliation>false</polishAffiliation>
					<order>1</order>
					<instituteAffiliation>Center for Research and Development in Agri-food Systems and Sustainability (CISAS), Instituto Politécnico de Viana do Castelo, Rua Escola Industrial e Comercial Nun’Alvares 4900-347, Viana do Castelo, Portugal</instituteAffiliation>
					<role>LEAD_AUTHOR</role>
				</author>
				<author>
					<name>Ravneet</name>
					<name2></name2>
					<surname>Bhuller</surname>
					<email></email>
					<polishAffiliation>false</polishAffiliation>
					<order>2</order>
					<instituteAffiliation>National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, United Kingdom</instituteAffiliation>
					<role>AUTHOR</role>
				</author>
			</authors>
			<references>
				<reference>
					<unparsedContent>Broussard, J., Peterson, M., Fox, P. (1995). Changes in clinical and laboratory findings in cats with hyperthyroidism from 1983 to 1993. J Am Vet Med Assoc. 206(3): 302-305.</unparsedContent>
					<order>1</order>
					<doi></doi>
				</reference>
				<reference>
					<unparsedContent>Peterson, M. (2020). Hyperthyroidism in cats: considering the impact of treatment modality on quality of life for cats and their wwners. Vet Clin North Am Small Anim Pract. 50(5): 1065-1084. PMid:32665137</unparsedContent>
					<order>2</order>
					<doi>10.1016/j.cvsm.2020.06.004</doi>
				</reference>
				<reference>
					<unparsedContent>Peterson, M., Kintzer, P., Cavanagh, P., Fox, P., Fergusson, D., Johnson, G., Becker, D. (1983). Feline hyperthyroidism: pretreatment clinical and laboratory evaluation of 131 cases. J Am Vet Med Assoc. 183(1): 103-110.</unparsedContent>
					<order>3</order>
					<doi></doi>
				</reference>
				<reference>
					<unparsedContent>Trepanier, L. (2006). Medical management of hyperthyroidism. Clin Tech Small Anim Pract. 21(1): 22-28. PMid:16584027</unparsedContent>
					<order>4</order>
					<doi>10.1053/j.ctsap.2005.12.004</doi>
				</reference>
				<reference>
					<unparsedContent>Forrester, S., Towell, T., Shenoy, K. (2012). Nutritional management of feline hyperthyroidism. Conference Proceedings of the Veterinary Medical Association, 130th Annual Meeting, Iowa: p.87-91 [cited 2022 February, 15] https://www.avmi.net/information/hyperthyroid-hints/nutritional-management-of-feline-hyperthyroidism</unparsedContent>
					<order>5</order>
					<doi></doi>
				</reference>
				<reference>
					<unparsedContent>Higgs, P., Murray, J., Hibbert, A. (2014). Medical management and monitoring of the hyperthyroid cat: a survey of UK general practitioners. J Feline Med Surg. 16(10): 788-795. PMid:24423813</unparsedContent>
					<order>6</order>
					<doi>10.1177/1098612X13519633</doi>
				</reference>
				<reference>
					<unparsedContent>Hofmann, G., Marks, S., Taboada, J., Hosgood, G., Wolfsheimer, K. (2003). Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg. 5(2): 77-82.</unparsedContent>
					<order>7</order>
					<doi>10.1016/S1098-612X(02)00095-5</doi>
				</reference>
				<reference>
					<unparsedContent>Naan, E., Kirpensteijn, J., Kooistra, H., Peeters, M. (2006). Results of thyroidectomy in 101 cats with hyperthyroidism. Vet Surg. 35(3): 287-293. PMid:16635010</unparsedContent>
					<order>8</order>
					<doi>10.1111/j.1532-950X.2006.00146.x</doi>
				</reference>
				<reference>
					<unparsedContent>Peterson, M., Becker, D. (1995). Radioiodine treatment of 524 cats with hyperthyroidism. J Am Vet Med Assoc. 207(11): 1422-1428.</unparsedContent>
					<order>9</order>
					<doi></doi>
				</reference>
				<reference>
					<unparsedContent>Slater, M., Geller, S., Rogers, K. (2001). Long-term health and predictors of survival for hyperthyroid cats treated with iodine 131. J Vet Intern Med. 15(1): 47-51. PMid:11215911</unparsedContent>
					<order>10</order>
					<doi>10.1111/j.1939-1676.2001.tb02298.x</doi>
				</reference>
				<reference>
					<unparsedContent>Milner, R., Channell, C., Levy, J., Schaer, M. (2006). Survival times for cats with hyperthyroidism treated with iodine 131, methimazole, or both: 167 cases (1996-2003). J Am Vet Med Assoc. 228(4): 559-563. PMid:16478432</unparsedContent>
					<order>11</order>
					<doi>10.2460/javma.228.4.559</doi>
				</reference>
				<reference>
					<unparsedContent>Vagney, M., Desquilbet, L., Reyes-Gomez, E., Delisle, F., Devauchelle, P., Rodriguez-Piñeiro, M., Rosenberg, D., Fornel-Thibaud, P. (2018). Survival times for cats with hyperthyroidism treated with a 3.35 mCi iodine-131 dose: a retrospective study of 96 cases. J Feline Med Surg. 20(6): 528-534. PMid:28699814</unparsedContent>
					<order>12</order>
					<doi>10.1177/1098612X17718416</doi>
				</reference>
				<reference>
					<unparsedContent>Williams, T., Peak, K., Brodbelt, D., Elliot, J., Syme, H. (2010). Survival and the development of azotemia after treatment of hyperthyroid cats. J Vet Intern Med. 24(4): 863-869. PMid:20649748</unparsedContent>
					<order>13</order>
					<doi>10.1111/j.1939-1676.2010.0550.x</doi>
				</reference>
				<reference>
					<unparsedContent>Berent, A., Drobatz, K., Ziemer, L., Johnson, V., Ward, C. (2007). Liver function in cats with hyperthyroidism before and after 131I therapy. J Vet Intern Med. 21(6): 1217-1223. PMid:18196729</unparsedContent>
					<order>14</order>
					<doi>10.1111/j.1939-1676.2007.tb01941.x</doi>
				</reference>
				<reference>
					<unparsedContent>Gunn-Moore, D. (2006). Considering old cats. J Small Anim Pract. 47(8): 430-431. PMid:16911109</unparsedContent>
					<order>15</order>
					<doi>10.1111/j.1748-5827.2006.00199.x</doi>
				</reference>
				<reference>
					<unparsedContent>Olczac, J., Jones, B., Pfeiffer, D., Squires, R., Morris, R., Markwell, P., (2005). Multivariate analysis of risk factors for feline hyperthyroidism in New Zealand. N Z Vet J. 53(1): 53-58. PMid:15731835</unparsedContent>
					<order>16</order>
					<doi>10.1080/00480169.2005.36469</doi>
				</reference>
				<reference>
					<unparsedContent>Lipinski, M., Froenicke, L., Baysac, K., Billings, N., Leutenegger, C., Levy, A., Longeri, M., et al. (2008). The ascent of cat breeds: genetic evaluations of breeds and worldwide random-bred populations. Genomics 91(1): 12-21. PMid:18060738 PMCid:PMC2267438</unparsedContent>
					<order>17</order>
					<doi>10.1016/j.ygeno.2007.10.009</doi>
				</reference>
				<reference>
					<unparsedContent>Benson, J., Hostetler, J., Onorato, D., Johnson, W., Roelke, M., O’Brien, S., Jansen, D., Oli, M. (2011). Intentional genetic introgression influences survival of adults and subadults in a small, inbred felid population. J Anim Ecol. 80(5): 958-967. PMid:21338353 PMCid:PMC6993175</unparsedContent>
					<order>18</order>
					<doi>10.1111/j.1365-2656.2011.01809.x</doi>
				</reference>
				<reference>
					<unparsedContent>Scarlett, J., Moise, N., Rayl, J. (1988). Feline hyperthyroidism: a descriptive and case-control study. Prev Vet Med. 6(4): 295-309.</unparsedContent>
					<order>19</order>
					<doi>10.1016/0167-5877(88)90041-4</doi>
				</reference>
				<reference>
					<unparsedContent>Kass, P., Peterson, M., Levy, J., James, K., Becker, D., Cowgill, L. (1999). Evaluation of environmental, nutritional, and host factors in cats with hyperthyroidism. J Vet Intern Med. 13(4): 323-329. PMid:10449223</unparsedContent>
					<order>20</order>
					<doi>10.1111/j.1939-1676.1999.tb02189.x</doi>
				</reference>
				<reference>
					<unparsedContent>Pittari, J., Rodan, I., Beekma, G., Gunn-Moore, D., Polzin, D., Taboada, J., Tuzio, H., Zoran, D. (2009). American association of feline practitioners. Senior care guidelines. J Feline Med Surg. 11(9): 763-778. PMid:19712895</unparsedContent>
					<order>21</order>
					<doi>10.1016/j.jfms.2009.07.011</doi>
				</reference>
				<reference>
					<unparsedContent>Platinga, E., Everts, H., Kastelein, A., Breynan, A. (2005). Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Vet Rec. 157(7): 185-187. PMid:16100367</unparsedContent>
					<order>22</order>
					<doi>10.1136/vr.157.7.185</doi>
				</reference>
				<reference>
					<unparsedContent>Boyd, L.M., Langston, C., Thompson, K., Zivin, K., Imanishi, M. (2008). Survival in cats with naturally occurring chronic kidney disease (2000-2002). J Vet Intern Med. 22(5): 1111-1117. PMid:18691369</unparsedContent>
					<order>23</order>
					<doi>10.1111/j.1939-1676.2008.0163.x</doi>
				</reference>
				<reference>
					<unparsedContent>Wakeling, J., Moore, K., Elliot, J., Syme, H. (2008). Diagnosis of hyperthyroidism in cats with mild chronic kidney disease. J Small Anim Pract. 49(6): 287-294. PMid:18422499</unparsedContent>
					<order>24</order>
					<doi>10.1111/j.1748-5827.2008.00544.x</doi>
				</reference>
				<reference>
					<unparsedContent>van Hoek, I., Lefebvre, H., Peremans, K., Meyer, E., Croubels, S., Vandermeulen, E., Kooistra, H., et al. (2009). Short- and long-term follow-up of glomerular and tubular renal markers of kidney function in hyperthyroid cats after treatment with radioiodine. Domest Anim Endocrinol. 36(1): 45-56. PMid:19010632</unparsedContent>
					<order>25</order>
					<doi>10.1016/j.domaniend.2008.10.001</doi>
				</reference>
				<reference>
					<unparsedContent>den Hollander, J., Wulkan, R., Mantel, M., Berghout, A. (2005). Correlation between severity of thyroid dysfunction and renal function. Clin Endocrinol (Oxf). 62(4): 423-427. PMid:15807872</unparsedContent>
					<order>26</order>
					<doi>10.1111/j.1365-2265.2005.02236.x</doi>
				</reference>
				<reference>
					<unparsedContent>Peterson, M., Kintzer, P., Hurvitz, A. (1988). Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med. 2(3): 150-157. PMid:3265728</unparsedContent>
					<order>27</order>
					<doi>10.1111/j.1939-1676.1988.tb02812.x</doi>
				</reference>
				<reference>
					<unparsedContent>Scardale Vets. (2020). Springwood Vets. Radioiodin treatment of hyperthyroidism in cats. [cited 2020 November 12]. http://www.scarsdalevets.com/wp-content/uploads/2018/04/Radioiodine-Treatment-of-Hyperthyroidism-1.pdf</unparsedContent>
					<order>28</order>
					<doi></doi>
				</reference>
			</references>
		</article>
	</issue>
</ici-import>